Skip to main content
Premium Trial:

Request an Annual Quote

Pan-European Pathogenomics Initiative Gets $24M

NEW YORK (GenomeWeb News) – Thirteen new genomics projects will receive funding and are underway in Europe under the ERA-Net Pathogenomics initiative, which is focused on using genomics to study diagnosis, monitoring, prevention, and treatment of infectious diseases.

The research teams will receive a total of €17 million ($23.8 million) over three years to conduct applied genomics studies, with the funding coming from the countries involved, including Germany, Austria, Finland, France, Hungary, Portugal, Slovenia, and Spain.

The scientific teams will focus on different groups of pathogens, such as Neisseria, Pseudomonas, Clostridium, Helicobacter, Escherichia, Streptococcus, Chlamydia, and Aspergillus.

"In the field of pathogenomics, basic researchers all too often work within isolated networks, although contacts with clinicians and companies are extremely important," explained Julio Barbas, of the Spanish Ministry for Science and Innovation. "Only through collaboration will we be able to deliver results from bench to bedside."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.